Skip to content

Home
About Us
Areas of Focus
- Tecarfarin For Chronic Anticoagulation
- Frunexion For Acute Anticoagulation
  - Overview
  - Cardiac Surgery
Research & Development
Investors

Home
About Us
Areas of Focus
- Tecarfarin For Chronic Anticoagulation
- Frunexion For Acute Anticoagulation
  - Overview
  - Cardiac Surgery
Research & Development
Investors

Analyst Coverage

Analyst Coverage

H.C. Wainwright & Co.
Joseph Pantginis, Ph.D.
646-975-6968
[email protected]

Noble Capital Markets
Robert LeBoyer
212-896-4625
[email protected]

Contact

Cadrenal Therapeutics, Inc.
822 North A1A
Ponte Vedra, FL 32082
[email protected]

Linkedin Youtube

Site Links

Home
Investors
Email Alerts
Contact
Privacy Policy

Home
Investors
Email Alerts
Contact
Privacy Policy

Our Company

About Us
Management Team
Board of Directors
Scientific Advisory Board

About Us
Management Team
Board of Directors
Scientific Advisory Board

Research & Development

Tecarfarin
ESKD + AFib
LVAD
Frunexian
Cardiac Surgery
Pipeline

Tecarfarin
ESKD + AFib
LVAD
Frunexian
Cardiac Surgery
Pipeline

Sign Up for Email Alerts

Copyright 2025 Cadrenal Therapeutics. All Rights Reserved.

Skip to content

Accessibility Tools

Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset

We use cookies to monitor and analyze how our site is used. By using our site, you agree to our use of cookies.Accept Privacy policy